Eurofins Panlabs strengthens drug discovery services with GE Healthcare’s Cytiva™ Cardiomyocytes
July 25, 2013
Eurofins Scientific (EUFI.PA), the world leader in food, environment and pharmaceutical products testing, has signed an agreement with GE Healthcare for the exclusive right to offer GE Healthcare’s Cytiva™ Cardiomyocytes for drug discovery and early development cardio toxicity screening services. The agreement allows Eurofins Panlabs to provide a unique offering for an early predictive measure [...]
Trovagene Announces Issuance of Broad MicroRNA Patent
July 24, 2013
SAN DIEGO, -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, announced the issuance of US patent 8,486,626, "Methods of detecting cell-free miRNA in urine and blood." The patent pertains to the detection and quantitation of microRNA (miRNA) using a wide variety of technologies and platforms. MicroRNAs are known to play critical roles [...]
3D Biomatrix Files Patent for Hanging Drop Transfer Plate Technology
July 24, 2013
Ann Arbor, MI - 3D Biomatrix, a leader in three-dimensional (3D) cell culture products, is pleased to announce that it has filed a patent for its technology for transferring spheroids from the company’s 96-well or 384-well Perfecta3D Hanging Drop Plates to a receiving plate for analysis of the spheroids. The transfer plate designed for the [...]
LifeSpan BioSciences Expands IHC-plusTM Product Line To More Than 10,000 Antibodies
July 24, 2013
SEATTLE, WA, -- LifeSpan BioSciences, Inc.(LSBio), a leading provider of antibodies for researchers worldwide, has increased the number of validated IHC-plusTM antibodiesavailable in its catalog to more than 10,000. With this increase, LSBiois well on its way to its goal of building the world's largest catalog of 20,000 well characterized, IHC-validated reagent antibodies. Overall, LSBiohas [...]
July 24, 2013
LGC is pleased to announce the release of a new automated nucleic acid extraction platform - oKtopureTM – which will drive significant increases in throughput and productivity while enabling reductions in consumable costs of up to 50%. The new oKtopureTM DNA extraction platform combines higher throughput with high quality DNA extractions and is capable of [...]
July 24, 2013
A line of highly sophisticated circulating water baths that makes it simple to create and run multi-step ramp and soak temperature programs as well as frequently used single temperature testing protocols is now available from PolyScience. Designed with the work habits and needs of laboratory personnel in mind, PolyScience Performance Programmable Circulating Baths feature an [...]
July 24, 2013
SUNNYVALE, Calif.–- Ernst & Young LLP announced that Mark Fischer-Colbrie, CEO and President, and Rich Ellson, Co-Founder of Labcyte Inc., received the Ernst & Young Entrepreneur Of The Year® 2013 Award in the Life Sciences category in Northern California. The award recognizes outstanding entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, [...]
Synthetic Cannabinoids Identifiable in the Field with Handheld Narcotics Analyzer
July 24, 2013
Law enforcement personnel are now better equipped to address the emerging threat of synthetic drugs with the latest software update for the Thermo Scientific TruNarc, a handheld analyzer used for onsite analysis of narcotics and other drugs of abuse. TruNarc v1.3 provides the capability to identify cannabinoids in final sprayed form and in bulk form. [...]
MIMETAS Appoints Biotech Pioneer Herbert Heyneker as Chairman of the Board
July 24, 2013
MIMETAS today announces the appointment of Herbert L. Heyneker, Ph.D. as Chairman of the Board of Directors. Dr. Heyneker will be supporting MIMETAS in her mission to develop high-throughput Organ-on-a-Chip products for predictive therapy testing. “Organ-on-a-Chip technology is extremely hot in the United States today. But none of the technologies I’ve seen so far comes [...]
Cerilliant Introduces Certified Spiking Solutions® of Bath Salt Metabolites
July 24, 2013
ROUND ROCK, TEXAS –– Cerilliant introduces seven new Certified Spiking Solutions® of bath salt metabolites. The new products are 1.0 mg/mL (as free base) in methanol for the primary urinary metabolites of bath salt cathinones, mephedrone, buphedrone, pentedrone, flephedrone, N-ethylcathinone, and 4-methylethcathinone. For GC/MS and LC/MS methods that quantify concentrations of synthetic cathinone metabolites, Cerilliant [...]
